Purchase Order HHSN272201400088P

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Fisher Bioservices Inc. for monthly project management services on January 2, 2013, with a ceiling value of $51,712.91 and an ultimate completion date of October 31, 2013.</p> <p>Work is performed at Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Fisher Bioservices Inc., Clinical Trials Division, valued at $15,378.24 on April 25, 2024. The order covers testing laboratories and storage services, performed in Rockville, Maryland. The purchase order is firm fixed price with an ultimate completion date of March 31, 2025. No small business set-aside was applied.</p>

The National Institute of Allergy and Infectious Diseases issued a delivery order to Fisher Bioservices Inc. on August 1, 2021, with a ceiling value of $305,770.92 for biospecimen freezer storage services. This is a firm fixed price delivery order with no set-aside. Place of performance is North Bethesda, MD. Ultimate completion date is May 16, 2026. Fisher Bioservices' Clinical Trials Division, a subsidiary of Thermo Electron Corporation, provides biorepository and scientific services including...

The National Institute of Allergy and Infectious Diseases issued a delivery order to Fisher Bioservices Inc. on November 26, 2018, with a ceiling value of $216,313.06 for specimen repository services. Place of performance is Rockville, MD. The order is firm fixed price with an ultimate completion date of January 31, 2020. Fisher Bioservices provides comprehensive storage, maintenance, and distribution services for biological specimens and research materials supporting federal research...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $12,565 delivery order to Fisher Bioservices Inc. Clinical Trials Division under the pre-existing Preclinical Services for HIV Therapeutics master IDIQ contract. The purpose of this task order is for Fisher Bioservices to develop and deliver a Quality Assurance/Quality Control plan in support of NIH's work concerning quality assurance and quality control....

The National Institute of Allergy and Infectious Diseases awarded a $29.4 million definitive contract to Fisher Bioservices Inc. on September 16, 2022, for clinical materials services supporting the Division of Microbiology and Infectious Diseases under Executive Order 14398. The contract calls for receiving, storing, packaging, shipping, acquiring, testing, and disposing of clinical agents and specimens in support of NIAID clinical trials. On contract execution, Fisher Bioservices transferred...

The National Institute of Allergy and Infectious Diseases awarded a definitive contract to Fisher Bioservices Inc., Clinical Trials Division, for the Clinical Research Products Development Center on June 16, 2020, with a ceiling value of $86.43 million and ultimate completion date of June 15, 2027. The originating solicitation, posted in July 2018, sought cGMP-compliant pharmaceutical services and study product management supporting over 80 HIV/AIDS and related clinical trials annually conducted...

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to The Emmes Company, LLC on August 16, 2016, with a ceiling value of $283,640.91 for clinical monitoring services.</p> <p>Place of performance is Westlake, MD. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of April 30, 2019. No set-aside was used for this delivery order.</p>

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order to Fisher Bioservices Inc., Clinical Trials Division, a subsidiary of Thermo Electron Corporation, for professional moving and storage of ultra-low temperature (ULT) equipment with samples. This $16,478.17 firm fixed-price delivery order, issued on March 1, 2023, with completion by February 29, 2024, represents work under the FY26 UDO Initiative and leverages the company's established expertise in...

This is a $30,595,505.93 cost-plus-fixed-fee definitive contract awarded by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) to Fisher Bioservices Inc.'s Clinical Trials Division, a division of Thermo Electron Corporation Financial Services Division. The contract, which has a completion date of July 14, 2023, is for Division of Microbiology and Infectious Diseases (DMID) Clinical Materials Services. The...